Neil Stahl - Feb 26, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil E. Stahl
Stock symbol
REGN
Transactions as of
Feb 26, 2024
Transactions value $
$0
Form type
4
Date filed
2/28/2024, 04:04 PM
Previous filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock -Gift $0 -1,020 -1.96% $0.00 50,999 Feb 26, 2024 Direct
holding REGN Common Stock 5,834 Feb 26, 2024 By 401(k) Plan
holding REGN Common Stock 4,605 Feb 26, 2024 by Spouse as Trustee